Oral Micronized Progesterone Cost in Idaho (2026)

What Oral Micronized Progesterone Actually Costs in Idaho

The price you pay depends on three variables: brand vs. generic vs. compounded, your pharmacy, and whether you carry prescription coverage. Brand-name Prometrium (manufactured originally by Solvay, now AbbVie) lists at $180/month for a 30-capsule supply of 100 mg or 200 mg capsules. Most Idaho women do not pay that figure. Generic micronized progesterone capsules, bioequivalent to Prometrium and approved by the FDA under the same NDA pathway, average $45/month cash-pay across Idaho retail pharmacies in 2026 1. Independent and chain pharmacies in Boise, Idaho Falls, and Meridian cluster between $38 and $52 for a 30-day generic supply without insurance, based on current GoodRx and pharmacy survey data.

Compounded oral micronized progesterone from a licensed 503A compounding pharmacy costs approximately $25/month in Idaho. This option requires a patient-specific prescription and a pharmacy registered with the Idaho Board of Pharmacy under section 503A of the Federal Food, Drug, and Cosmetic Act 2. The $25 price point reflects the lower overhead of bulk progesterone powder, though quality assurance varies between compounders. The Endocrine Society and ACOG both note that FDA-approved formulations offer standardized potency and dissolution testing that compounded products may lack 3.

Generic vs. Brand vs. Compounded: Which Option Saves the Most?

Generic micronized progesterone is the best balance of cost and quality for most Idaho patients. It costs 75% less than brand Prometrium while meeting identical FDA bioequivalence standards. A 90-day supply through mail-order pharmacies can drop the per-month cost to $30, $35, and some Idaho Albertsons and Fred Meyer locations price-match mail-order rates when asked directly.

Brand Prometrium may still make sense for women with peanut allergies who need the specific inactive-ingredient profile or for patients whose insurers have negotiated a brand-preferred formulary tier. AbbVie offers a Prometrium savings card that can reduce copays to $25/month for commercially insured patients, though the card does not apply to government-funded plans like Medicaid, Medicare Part D, or Tricare 4.

Compounded progesterone at $25/month is the cheapest route, but it carries a regulatory caveat. The FDA does not verify the potency or purity of 503A compounded drugs the way it does for approved generics. A 2001 FDA survey found that 34% of compounded progesterone samples failed potency testing, with some delivering as little as 67.5% of the labeled dose 5. For women using progesterone specifically for endometrial protection on estrogen therapy, underdosing is a safety concern. The PEPI trial (N=875) demonstrated that 200 mg micronized progesterone taken cyclically for 12 days per cycle prevented endometrial hyperplasia as effectively as medroxyprogesterone acetate, but that protection depends on consistent dosing 6.

Idaho Medicaid and Progesterone: What's Covered?

Idaho Medicaid does not cover oral micronized progesterone when prescribed for endometrial protection during hormone replacement therapy. This exclusion applies to both brand Prometrium and generic formulations. Idaho's Medicaid formulary, administered through Magellan Rx Management, classifies HRT-indication progesterone as a non-preferred agent without a listed therapeutic alternative in the same class 7.

There is a narrow exception. Idaho Medicaid does cover progesterone for prevention of preterm birth (the 17-alpha-hydroxyprogesterone caproate indication) and for luteal phase support in fertility treatment, because those indications fall under obstetric rather than HRT coverage categories. Women on Idaho Medicaid who need endometrial protection may qualify for manufacturer patient-assistance programs or for compounded progesterone at the $25/month cash-pay rate, which is often cheaper than a Medicaid copay would be even if the drug were covered.

For dual-eligible patients (Medicaid plus Medicare), Medicare Part D plans in Idaho have mixed coverage. Of the 24 Part D plans available in Idaho for 2026, approximately 70% list generic micronized progesterone on Tier 2 with copays ranging from $5 to $20/month. Checking the Medicare Plan Finder at medicare.gov with the drug's NDC is the fastest way to confirm individual plan coverage 8.

Private Insurance Coverage in Idaho

Most commercial insurance plans in Idaho cover generic oral micronized progesterone. Blue Cross of Idaho, Regence BlueShield, SelectHealth, and PacificSource all list generic progesterone capsules on their 2026 formularies, typically at Tier 1 or Tier 2. Copays range from $0 to $15/month depending on plan design.

Brand Prometrium sits on Tier 3 (non-preferred brand) for the majority of Idaho commercial plans, with copays between $40 and $75/month. A prior authorization is sometimes required to access brand when a generic is available. Step therapy protocols may apply: the insurer requires a trial of generic progesterone before approving brand coverage.

Self-funded employer plans, which cover roughly 60% of commercially insured Idahoans according to the Kaiser Family Foundation, set their own formularies and may have different tier placements 9. Human resources departments or the plan's pharmacy benefit manager (Express Scripts, CVS Caremark, or OptumRx) can provide the specific formulary lookup.

Idaho's state employee health plan (administered through the Office of Group Insurance) covers generic micronized progesterone with a $10 copay for a 30-day supply and $25 for a 90-day mail-order supply.

Compounded Progesterone Legality and Access in Idaho

Compounded oral micronized progesterone is legal in Idaho through licensed 503A pharmacies. Section 503A of the Federal FD&C Act permits patient-specific compounding by state-licensed pharmacies when a prescriber writes an individualized prescription 2. Idaho's Board of Pharmacy follows this federal framework without imposing additional restrictions on progesterone compounding specifically.

Idaho has approximately 15 compounding pharmacies with active 503A registration, concentrated in the Boise-Nampa-Meridian corridor, with additional locations in Pocatello, Twin Falls, and Coeur d'Alene. Several national compounding pharmacies (Help Pharmacy, Belmar Pharmacy) also ship to Idaho addresses, though interstate compounding must comply with both the originating state's and Idaho's pharmacy regulations.

The clinical question is not legality but reliability. Dr. JoAnn Manson, chief of preventive medicine at Brigham and Women's Hospital, stated in a 2020 JAMA editorial: "FDA-approved micronized progesterone formulations should be the default choice for menopausal hormone therapy because of their established safety profile in randomized trials" 10. When a patient chooses compounding for cost reasons, prescribers should verify the pharmacy's accreditation through the Pharmacy Compounding Accreditation Board (PCAB) or a similar third-party program.

Telehealth Prescribing of Progesterone in Idaho

Idaho permits telehealth prescribing of oral micronized progesterone. The Idaho Board of Medicine allows prescribers to establish a patient-provider relationship via synchronous audio-video visit, and progesterone is not a controlled substance, so no in-person visit requirement applies 11.

Several telehealth platforms serve Idaho for HRT prescribing, including HealthRX. A typical telehealth HRT consultation in Idaho runs $75, $150 for the initial visit and $50, $99 for follow-ups. The prescription can be sent electronically to any Idaho pharmacy, including compounding pharmacies. Combined with generic pricing of $45/month or compounded pricing of $25/month, total annual out-of-pocket for progesterone via telehealth (including two visits per year) is approximately $690, $790 for generic or $450, $550 for compounded.

This matters for Idaho's rural population. Roughly 36% of Idaho residents live in counties classified as rural by the USDA Economic Research Service. For women in areas like Salmon, Challis, or Grangeville, the nearest endocrinologist may be 100+ miles away. Telehealth removes that barrier entirely.

How to Lower Your Progesterone Cost in Idaho

Several strategies can bring the effective cost below the $45/month generic average.

Use a discount card. GoodRx, RxSaver, and SingleCare coupons reduce generic progesterone to $20, $35 at major Idaho chains including Walgreens, CVS, Walmart, and Albertsons. These cards work regardless of insurance status and can sometimes beat insured copays.

Request 90-day fills. Most Idaho pharmacies and all major mail-order services offer 90-day supplies at a discount, typically 2.0 to 2.5 times the 30-day price rather than 3 times, saving $10, $15 per quarter.

Compare compounding pharmacies. Prices for compounded oral micronized progesterone in Idaho range from $18 to $35/month depending on the pharmacy. Calling three compounders for a price quote takes 15 minutes and can save $120/year.

Check manufacturer assistance. AbbVie's Prometrium patient assistance program provides free brand-name medication to uninsured patients with household income below 200% of the federal poverty level ($31,200 for a single individual in 2026). Application is available through the AbbVie patient assistance portal 4.

Ask about therapeutic alternatives. If cost is the primary barrier, prescribers may consider vaginal progesterone (Endometrin, Crinone) or the levonorgestrel IUD (Mirena) for endometrial protection, both of which may have different insurance coverage profiles. The 2022 Endocrine Society guidelines note that the levonorgestrel IUD provides effective endometrial protection during estrogen therapy and is covered by most Idaho plans under the ACA contraceptive mandate at zero cost-sharing 12.

Clinical Context: Why Progesterone Matters on HRT

Oral micronized progesterone is not optional for women with a uterus who take estrogen therapy. Without progesterone, unopposed estrogen increases the risk of endometrial hyperplasia and endometrial cancer by 2- to 10-fold depending on dose and duration 13. The PEPI trial established that micronized progesterone at 200 mg/day for 12 days per cycle offered the same endometrial protection as medroxyprogesterone acetate 10 mg/day while producing a more favorable lipid profile: HDL cholesterol increased by 4.1 mg/dL with micronized progesterone versus a decrease of 2.4 mg/dL with medroxyprogesterone acetate 6.

The Women's Health Initiative (WHI) used medroxyprogesterone acetate (Provera), not micronized progesterone, in its estrogen-plus-progestogen arm. The increased breast cancer risk observed in that arm (HR 1.26, 95% CI 1.00 to 1.59) has not been replicated in observational data on micronized progesterone. The E3N French cohort study (N=80,377) found no significant increase in breast cancer risk with estrogen plus micronized progesterone over a median 8.1 years of follow-up (RR 1.00, 95% CI 0.83 to 1.22) 14.

These safety differences matter for Idaho women making cost-benefit calculations. Choosing a cheaper but less reliable compounded product to save $20/month introduces dosing variability at the exact point where consistent dosing prevents uterine pathology.

Dosing and Administration for Idaho Prescribers

The FDA-approved dosing for endometrial protection is 200 mg orally at bedtime for 12 consecutive days per 28-day cycle (cyclic regimen) or 100 mg nightly (continuous regimen) 1. Bedtime dosing is standard because micronized progesterone produces a metabolite, allopregnanolone, that causes drowsiness. This side effect is dose-dependent and typically resolves within 1 to 2 weeks of initiation.

Dr. Nanette Santoro, professor of obstetrics and gynecology at the University of Colorado, noted in a 2021 review: "The soporific effect of oral micronized progesterone is often therapeutic rather than problematic, particularly for perimenopausal women with concurrent sleep disruption" 15.

Progesterone capsules contain peanut oil. Patients with confirmed peanut allergy should use a compounded formulation in an alternative oil base (olive oil, safflower oil) or switch to vaginal micronized progesterone, which avoids first-pass hepatic metabolism entirely. The compounded alternative in this specific clinical scenario is a medically justified use of 503A compounding rather than a cost-driven substitution.

Standard monitoring includes an annual endometrial thickness assessment via transvaginal ultrasound if breakthrough bleeding occurs, and periodic lipid panels given progesterone's interaction with HDL metabolism 3. Idaho prescribers should document the specific formulation (brand, generic NDC, or compounding pharmacy) in the medical record for pharmacovigilance purposes.